A new era in the treatment of urothelial carcinoma

被引：0
|
作者：
Faltas, Bishoy [1 ,2 ]
机构：
[1] Weill Cornell Med, Dept Hematol & Oncol, New York, NY 10065 USA
[2] Weill Cornell Med, Dept Cell & Dev Biol, New York, NY 10065 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2023年 / 41卷 / 10期
关键词：
Urothelial carcinoma; FGFR3; inhibition; Antibody-drug conjugates (ADCs); Immunotherapy; ANTIBODY-DRUG CONJUGATE; OPEN-LABEL; CANCER; MULTICENTER;
D O I：
10.1016/j.urolonc.2023.08.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The advances in targeted therapies, immunotherapy, and the recent emergence of antibody-drug conjugates (ADCs) herald a potential paradigm shift in treating patients with metastatic urothelial cancer. Yet, there are inherent challenges in utilizing these therapies, including the management of treatment-related toxicities. In this special Urologic Oncology: Seminars and Original Investigations issue, we review the latest developments and discuss insights into future research needs. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：395 / 397
页数：3
相关论文
共 50 条
  • [1] A new era in the detection of urothelial carcinoma by sequencing cell-free DNA
    Hayashi, Yujiro
    Fujita, Kazutoshi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S497 - S501
  • [2] Urothelial carcinoma in the era of immune checkpoint inhibitors
    Khalife, Nadine
    Chahine, Claude
    Kordahi, Manal
    Felefly, Tony
    Kourie, Hampig Raphael
    Saleh, Khalil
    IMMUNOTHERAPY, 2021, 13 (11) : 953 - 964
  • [3] Durvalumab for the treatment of urothelial carcinoma
    Alsharedi, M.
    Srivastava, R.
    Elmsherghi, N.
    DRUGS OF TODAY, 2017, 53 (12) : 647 - 652
  • [4] Immunotherapy for the Treatment of Urothelial Carcinoma
    Donin, Nicholas M.
    Lenis, Andrew T.
    Holden, Stuart
    Drakaki, Alexandra
    Pantuck, Allan
    Belldegrun, Arie
    Chamie, Karim
    JOURNAL OF UROLOGY, 2017, 197 (01): : 14 - 22
  • [5] Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?
    Andrew X. Zhu
    Annals of Surgical Oncology, 2010, 17 : 1247 - 1256
  • [6] Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?
    Zhu, Andrew X.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1247 - 1256
  • [7] Meta-Analysis of Age, Sex, and Race Disparities in the Era of Contemporary Urothelial Carcinoma Treatment
    Barsouk, Adam
    Elghawy, Omar
    Yang, Austin
    Sussman, Jonathan H.
    Mamtani, Ronac
    Mei, Lin
    CANCERS, 2024, 16 (19)
  • [8] New paradigms in the second line treatment for advanced and metastatic urothelial carcinoma
    Vidal, Natalia
    Puente, Javier
    ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (10): : 1007 - 1015
  • [9] Confocal Laser Endomicroscopy of Bladder and Upper Tract Urothelial Carcinoma: A New Era of Optical Diagnosis?
    Chen, Stephanie P.
    Liao, Joseph C.
    CURRENT UROLOGY REPORTS, 2014, 15 (09)
  • [10] Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy
    Sonpavde, Guru
    Pond, Gregory Russell
    RosenberG, Jonathan E.
    Choueiri, Toni K.
    Bellmunt, Joaquim
    Regazzi, Ashley Marie
    Mullane, Stephanie A.
    Necchi, Andrea
    Raggi, Daniele
    Lee, Jae-Lynn
    Lee, Soonil
    Simpson, Joe
    Derleth, Christina Louise
    Lin, Shih-Wen
    Bajorin, Dean F.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E961 - E967
12345